Natasha Hernday

Insider Reports History

Location
Incline Village, NV
Signature
/s/ James Pennington, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Sponsored

Holdings reported by Natasha Hernday:

Company Role Class Num Shares Value Price $ Report Date Ownership
Janux Therapeutics, Inc. Director Common Stock 8,731 $223,164 $25.56 11 Jun 2025 Direct
XOMA Royalty Corp Director Common Stock 9,006 $221,637 $24.61 21 May 2025 Direct
Janux Therapeutics, Inc. Director Stock Option (right to buy) 11,667 11 Jun 2025 Direct
ALPINE IMMUNE SCIENCES, INC. Director Stock Option (Right to buy) 0 20 May 2024 Direct

Insider Reports Filed by Natasha Hernday

Symbol Company Period Transactions Value $ Form Type Role Filing Time
JANX Janux Therapeutics, Inc. 11 Jun 2025 2 $0 4 Director 13 Jun 2025, 19:30
XOMA XOMA Royalty Corp 21 May 2025 1 $0 4 Director 23 May 2025, 16:47
JANX Janux Therapeutics, Inc. 19 Jul 2024 2 $0 4/A Director 24 Jul 2024, 20:00
JANX Janux Therapeutics, Inc. 19 Jul 2024 4 $0 4 Director 22 Jul 2024, 20:03
JANX Janux Therapeutics, Inc. 19 Jul 2024 0 $0 3 Director 22 Jul 2024, 20:01
/report/000162619924000100-hernday-natasha-2024-05-20 ALPINE IMMUNE SCIENCES, INC. 20 May 2024 5 $0 4 Director 20 May 2024, 20:13
XOMA XOMA Corp 15 May 2024 2 $0 4 Director 17 May 2024, 16:30
/report/000162619924000013-hernday-natasha-2024-01-02 ALPINE IMMUNE SCIENCES, INC. 02 Jan 2024 1 $0 4 Director 04 Jan 2024, 19:06
XOMA XOMA Corp 17 May 2023 1 $0 4 Director 19 May 2023, 16:30
/report/000162619923000018-hernday-natasha-2023-01-03 ALPINE IMMUNE SCIENCES, INC. 03 Jan 2023 1 $0 4 Director 05 Jan 2023, 17:58
XOMA XOMA Corp 18 May 2022 1 $0 4 Director 20 May 2022, 09:00
/report/000162619922000008-hernday-natasha-2022-01-03 ALPINE IMMUNE SCIENCES, INC. 03 Jan 2022 1 $0 4 Director 04 Jan 2022, 16:24
XOMA XOMA Corp 19 May 2021 1 $0 4 Director 21 May 2021, 16:30

Sponsored